Design Controls are FDA-required procedures in 21 CFR 820.30 that govern every phase from design planning to validation, proving a medical device meets user needs and remains safe and effective. Regulators examine these records during inspections and cite gaps on Form 483s or Warning Letters.
Table of Contents
- Definition & regulatory basis
- Why Are Medical Device Design Controls Important?
- Ten key Design-Control elements
- Common compliance gaps
- Phase-by-phase Design-Control process
- FDA enforcement trends
- Benchmark your Design-Control readiness
- FAQ
Definition & regulatory basis (21 CFR 820.30 & ISO 13485)
Design Controls constitute a closed-loop quality-system within 21 CFR 820.30 and ISO 13485 §7.3, requiring documented planning, inputs, outputs, reviews, verification, validation, transfer and DHF maintenance.
Why Are Medical Device Design Controls Important?
According to the U.S. FDA, medical device design controls “control the design process to assure that devices meet user needs, intended uses, and specified requirements.”
For medical device manufacturers, it is critical to have robust design controls as they help ensure quality, safety, and effectiveness of the end product. Design controls are particularly important for Class II and Class III medical devices while most Class I devices are exempt.
For one, in the United States, 21 CFR 820.30 mandates that a robust design-control system include human factors analysis under design input, design verification, and design validation.
Technical documentation for design controls includes summary reports, material certificates, plans, protocols, and reports.
According to one FDA investigator, if there are concerns about a manufacturer’s quality system, the investigator may take a closer look at areas such as design controls.
Related: There were 1,272 FDA 483 observations for design controls involving medical-device GMP operations over the past ten years. Contact Redica to see how we can help you stay on top of the latest GMP inspection trends to make your inspection preparation easier.
Design-Control Warning-Letter Citations
For examples of FDA Warning-Letter citations involving medical-device design controls, check out the following:
- A manufacturer of thermographic products received a Warning Letter in February 2019 due to lack of design-control features.
- A manufacturer’s DHF lacked design inputs among other requirements.
- A BIMO inspection in October 2019 found that design controls were not adequately implemented at a Hungarian device firm.
Ten key Design-Control elements
Common compliance gaps
Redica Warning-Letter analytics show recurring deficiencies:
- Missing or poorly defined design inputs
- Design reviews without independent reviewers
- Verification protocols lacking predefined acceptance criteria
- Design-validation samples not representative of production
- Out-of-date or incomplete Design History File (DHF)
Phase-by-phase Design-Control process
Design planning
Define responsibilities, schedules, deliverables and review gates. Update the plan as design evolves.
Design inputs
Translate user needs, intended use, regulatory and risk requirements into measurable specifications.
Design outputs
Drawings, BOMs, software code and test methods that meet—traceably—all approved inputs.
Design review
Formal checkpoints with independent reviewers; document action items and resolutions.
Design verification
Objective evidence the outputs meet inputs (bench tests, inspections, analysis).
Design validation
Evidence the final device meets user needs under actual or simulated conditions (clinical/animal/usability).
Design transfer & DHF upkeep
FDA enforcement trends (2021 – 2024)
Benchmark your Design-Control readiness
Need to benchmark your Design-Control readiness? Redica tracks every Form 483 & Warning Letter by 820.30 clause. Book a 15-minute walkthrough to see your risk profile in real time.
Frequently Asked Questions
What are Design Controls?
Documented procedures that define and control medical-device design from planning to validation and transfer.
What is 21 CFR 820.30?
The FDA Quality-System regulation section that mandates Design Controls for applicable devices.
How do Design Controls differ from ISO 13485 design requirements?
ISO 13485 §7.3 aligns closely but is less prescriptive; FDA enforces 820.30 under U.S. law.
What is the Design History File (DHF)?
A compilation of records demonstrating a device was developed in accordance with the approved design-control plan.
What is the difference between design verification and design validation?
Verification proves outputs meet inputs; validation confirms the final device meets user needs and intended use.
When are Design Controls required for Class I devices?
Only for those listed in 820.30(a) (e.g., devices automated with computer software).
Get a Demo
We can show you insights into any of your key suppliers, FDA investigators, inspection trends, and much more.